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AbstrACt
Objective Despite a high number of the internationally 
produced and implemented clinical guidelines, the 
adherence with them is still low in healthcare. This study 
aimed at exploring the perspectives and experiences 
of senior doctors and nurses towards the barriers of 
adherence to diabetes guideline.
setting The Palestinian Primary Health Care-Ministry of 
Health (PHC-MoH) and Primary Health Care-United Nations 
Relief and Works Agency for Palestine Refugees in the 
Near East (PHC- UNRWA) in Gaza Strip.
Participants Individual face-to-face in-depth interviews 
were conducted with 20 senior doctors and nurses who 
were purposefully selected.
Methods Qualitative design was employed using the 
theoretical framework by Cabana et al to develop an 
interview guide. Semi-structural and audio-recorded 
interviews were conducted. Data were transcribed 
verbatim and thematically analysed.
results The key theme barriers identified by participants 
that emerged from the analysed data were in regard of the 
PHC-MoH lack reimbursement, lack of resources and lack 
of the guideline trustworthiness, and in regard of PHC-
UNRWA the time constraints and the lack of the guideline 
trustworthiness. The two key subthemes elicited from the 
qualitative analysis were the outdated guideline and lack 
of auditing and feedback.
Conclusion The analysis identified a wide range of 
barriers against the adherence to diabetes guideline within 
the PHC-MoH and PHC-UNRWA. The environmental-related 
and guideline-related barriers were the most prominent 
factors influencing the guideline adherence. Our study can 
inform the policy makers and senior managers to develop 
a tailored interventions that can target the elicited barriers 
through a multifaceted implementation strategy.
IntrOduCtIOn 
Diabetes mellitus (DM) is an increasingly 
serious public health issue targeted for action 
by world leaders. It is a major cause of blind-
ness, kidney failure, heart attacks, stroke, 
lower limb amputation and can increase the 
overall risk of premature death and disability.1 
The global prevalence of this epidemic is 
increasing at an alarming rate. The Interna-
tional Diabetes Federation (IDF) estimates 
that, worldwide, about 425 million people 
aged 20–79 years have diabetes in 2017 with 
global prevalence of 8.8%.2 Approximately 
4.0 million people aged between 20 and 79 
years are estimated to die from diabetes in 
2017, which is equivalent to one death every 
8 s. Diabetes accounted for 10.7% of global 
all-cause mortality among people in this age 
group.2 Over the past decade, diabetes prev-
alence has risen faster in low-income and 
middle-income countries than in high-in-
come countries. In 2017, approximately 
38.7 million people, or 9.6% of adults aged 
20–79 years are living with diabetes in Middle 
East and North Africa. Diabetes is responsible 
for 318.036 regional deaths in adults aged 
20–79 years in 2017 (13% of all mortality).2 
In Palestine, despite few epidemiolog-
ical studies focused on the non-communi-
cable diseases including diabetes,3 the IDF 
referred to some figures on DM. Most studies 
were cross-sectional in nature and provided 
strengths and limitations of this study
 ► The strength of this study lies in the fact that it is 
the first qualitative study recruiting the framework 
by Cabana et al  that has provided in-depth under-
standing of the factors hindering the adherence to 
the Palestinian diabetes guideline.
 ► Interviews explored determinants of adherence to 
diabetes guideline from different work settings and 
positions.
 ► Only the perspectives of senior doctors and nurses 
were included in this study. The views and percep-
tions of frontline professionals should be addressed 
in future studies.
 ► The other limitation is that we focused on barriers 
of adherence to the diabetes guideline as a whole 
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estimates of the current prevalence for diabetes. In Gaza, 
getting valid and consistent estimates of diabetes preva-
lence over time seems to be difficult. A recent report by 
the United Nations for Relief and Works Agency for Pales-
tine Refugees in the Near East (UNRWA) showed that the 
prevalence rate of diabetes was 15.9% in the West Bank 
and 12.9% in the Gaza among the registered Palestinian 
refugees aged 40 years and older.4 It has been projected 
that the prevalence of DM among Palestinians will be 
approximately 23.4% in 2030.5
The Ministry of Health (MoH) and UNRWA have devel-
oped guidelines, adapted to the Palestinian context, for 
the management of DM in accordance with the recom-
mendations of relevant professional and academic inter-
national societies.3 Both guidelines are based on the WHO 
diabetes care guidelines. Despite a high number of the 
internationally produced and implemented Clinical Prac-
tice Guidelines (CPGs), the adherence with them is still 
low among healthcare workers.6 7 A common conceptual 
framework (Cabana et al) based on a systematic review on 
barriers to physician guideline adherence has been widely 
used.8 The framework encompasses three main barrier 
categories: knowledge-related barriers (lack of familiarity 
and lack of awareness); attitude-related barriers (lack of 
agreement, lack of self-efficacy, lack of outcome expec-
tancy and lack of motivation/inertia of previous practice) 
and behaviour-related barriers (patient factors, guideline 
factors and environmental factors). It has been advocated 
to analyse the barriers influencing the guidelines adher-
ence as an initially key step towards improving the adher-
ence to guidelines.9 Based on the framework by Cabana 
et al, this study aimed at investigating the perspectives 
and experiences of senior doctors and nurses towards the 
main barriers of adherence to diabetes guideline in both 




Individual interviews with key informants from different 
key positions were done to explore their perceptions and 
experiences on the barriers of the adherence to diabetes 
guideline. A sample of 20 key informants (senior doctors 
and nurses) who were managing/supervising the func-
tions related to chronic diseases at the MoH and UNRWA 
were purposefully selected.
Qualitative data collection
An interview guide was used that was developed based 
on the validated framework of Cabana et al8 to stan-
dardise reporting of barriers. The choice of the frame-
work by Cabana et al was based on the fact that it was 
the first framework developed to address the factors 
influencing guidelines adherence. In addition, the study 
by Cabana et al was based only on literature reviews that 
discussed doctors’ adherence, while this is an empirical 
study based on qualitative research. Specific items of the 
Cabana et al constructs (organisation constraints, lack of 
resources and lack of reimbursement) were tailored to 
match with the Palestinian local context.
A semi-structured interview approach was chosen in 
order provide more flexibility for both the participants 
and the researchers.10 This interview guide consisted of 
16 open-ended questions assessing the importance of 
guidelines, guideline use, resources, guideline contents, 
issues in actual practice interfering with guideline use 
and suggestions for supportive measures (see online 
supplementary file).
The key informant interviews were conducted by the 
first author (MR). The interviewees were contacted face-
to-face, and the average period time for the interviews 
ranged from 35 to 60 min. At the beginning of each 
interview, participants were given a full briefing on the 
purpose of the study, the format of the session and issues 
of confidentiality.
sample size
The key informants for the in-depth interviews were 
selected purposefully from different key positions. The 
snowball technique was used after identification of a 
set of potential key informants. The sample size was 
determined when saturation of themes was achieved. 
Regarding thematic saturation, 'the number of required 
subjects usually becomes obvious as the study progresses, 
as new categories, themes or explanations stop emerging 
from the data'.11 Thematic saturation in this study was 
achieved after conducting 20 individual interviews with 
no new themes appearing and themes repeating.
Analysis approach of the qualitative data
The interviews were audio-recorded, and data were tran-
scribed verbatim to facilitate analysis. All transcriptions 
were carried out by a professional transcriptionist with 
master degree. There was no identification of participants’ 
details during the transcription process. Participants were 
given a unique identifier to maintain anonymity, thus if 
on data analysis it is required to re-interview a particular 
participant, the code can be broken by the author and the 
participant can be re-contacted. The code was not broken 
in other circumstances and anonymity was preserved. 
The list of unique identifiers against names was kept on a 
secure file on the computer.
Data analysis consisted of developing a thematic frame-
work, consisting of five steps of ‘familiarisation’, ‘iden-
tifying a thematic framework’, ‘indexing’, ‘charting’ 
and ‘mapping and interpretation’.12 This method has 
been specifically developed for the analysis of qualitative 
data for policy-oriented studies.
Stage 1: familiarisation
The first author familiarised himself with all of the data 
through reading all the interview transcripts many times. 
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Stage 2: identifying a thematic framework
The first author went back through the summaries and 
listed the key notes/themes we had drawn-up at the 
familiarisation stage. A preliminary framework has been 
developed based on the model of adherence by Cabana 
et al, including the issues that were raised by interviewees. 
For those emergent issues that did not fit into the catego-
ries of the framework by Cabana et al, additional types of 
barriers were formulated.
Stage 3: indexing
All data were read and indexed (coded) according to the 
thematic framework. Indexing references were recorded 
in the margin of the transcript as a reference point. 
Sections of data were indexed with one or more codes 
(cross-indexing) wherever appropriate. The first author 
indexed the transcribed interviews with codes linked 
to the thematic framework. Then the coded texts were 
discussed with another PhD health policy researcher and 
coding was adjusted where appropriate. When neces-
sary, a third researcher was consulted. This process was 
repeated several times for all the interviews. Indexing 
allowed us to organise the data and to explore ways in 
which topics were interlinked.
Stage 4: charting
We used thematic charting to build up a picture of the 
data as a whole. Data were lifted and rearranged in tables 
(Microsoft Excel) to enable us to look at experiences and 
issues across the data set, not just the transcribed inter-
views. We drew up charts for thematic analysis, where data 
for each theme were collected from all episodes of inter-
view transcripts. Then we compared and investigated the 
views of each interviewee across different themes (looking 
across the rows) and the views of different interviewees 
about each theme (looking across the columns). We 
consulted the transcribed interviews and added extracts 
to the chart wherever necessary.
Stage 5: mapping and interpretation
Key themes which were developed from index points were 
then drawn together and mapped (subordinate themes 
into superordinate categories). The thematic framework 
was updated in the process of the analysis. This stage 
enabled us to define concepts, compare and contrast the 
perceptions or experiences, search for patterns and asso-
ciations and explanations and develop strategies.
Patient and public involvement
Patients and/or public were not involved.
results
Twenty interviews were conducted (10 in the PHC-MoH 
and 10 in the PHC-UNRWA) among different senior posi-
tions (16 doctors and 4 nurses) (table 1). The themes 
elicited from this study were grouped according to the 
framework domains by Cabana et al (table 2). The major 
barriers identified were lack of reimbursement, lack of 
resources, lack of time and lack of guideline trustwor-
thiness. The outdated guideline and lack of clinical 
audit and feedback (A&F) most frequently emerged as 
subthemes. The lists within the subcategory were organ-
ised according to the more often identified.
environmental-related factors
Environmental factors were the most prominent barrier 
related to behaviour of doctors and nurses in practising 
according to diabetes guideline. Particularly, lack of reim-
bursement, lack of resources, time constraints and lack of 
clinical A&F were often reported as barriers to guideline 
adherence.
Lack of reimbursement
There was a general consensus among all interviewees 
in the MoH that the lack of incentives was a key barrier 
against the guideline adherence. Participants reported 
that the monetary incentives is totally absent. Some 
mentioned that the deteriorated political and economic 
condition in Palestine enforced the government towards 
freezing any decision related to payment system or job 
promotion. Many compared the monetary incentives of 
the UNRWA and the MoH, and believed that the UNRWA 
staff are more motivated due to the higher salaries. The 
participants in the UNRWA acknowledged that their staff 
receive salaries one and half time higher than their coun-
terparts in the MoH. Moreover, they reported that the 
distinguished staff receive different kinds of incentives 
such as bonuses, annual awards or appreciation letters. 
Such incentives were rarely reported by the MoH inter-
viewees. Surprisingly, the majority of the MoH inter-
viewees argued that financial incentives appear to be the 
strongest barrier of guideline adherence. They defended 
Table 1 Demographic and clinical backgrounds of the 
interviewees
Characteristics 
Number of participants 
(n=20)
Age (years) 
  40–50 9
  51–60 11
Gender 
  Male 13
  Female 7
Work setting 
  PHC-MoH 10
  PHC-UNRWA 10
 Specialisation/position 
  Senior doctor 16
  Senior nurse 4
Years of experience 
  10–15 5
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such opinion by the view that in case of securing appro-
priate financial incentives, the professionals’ behaviour 
might be broadly improved and consequently the like-
lihood of guideline adherence could be increased. 
Others expected that considering an appropriate finan-
cial scheme can effectively increase the competition 
and continuous professional development on guideline 
adherence.
…generally, most of the staff are frustrated due to 
the poor salaries and lack of incentive. How can they 
be committed to provide the care according to the 
guideline recommendations while they are demo-
tivated… I can here say this proverb The one who 
does not have the thing, can't give it. (Senior doctor, 
MoH)
In our system, the personnel receive only fixed 
monthly salaries, no matter how many services they 
provide to patients. So there is no incentive for any 
additional tasks or for guideline adherence….unfor-
tunately, the current salaries are quite hard to satisfy 
the nurse’s needs. (Senior nurse, MoH)
The MoH interviewees stressed on the suggestion to 
review, perhaps to reform, the current payment system 
and link the monetary incentives to guideline adherence, 
particularly based on the quantity and quality of services 
provided to patients with diabetes.
Lack of resources
Lack of resources emerged as a central topic of concern 
in the MoH settings. All participants identified inade-
quacy of resources as principal barrier to the implementa-
tion of diabetes guideline. The participants discussed the 
need of resources as basic inputs that can lead to better 
processes and consequently to better adherence. They 
raised the issues of budget limitation and poor financial 
support to ensure the continuity of resources availability. 
Specific issues identified by participants included the 
frequent shortages in some drugs, laboratory kits and 
tests and nursing staff also. Although the UNRWA has 
its own stable finance route as a United Nations agency, 
few of interviewees expressed the need for more staff in 
order to effectively and appropriately apply the guideline 
recommendations. Some MoH participants described 
that the shortage of staff as an obstacle for implementa-
tion of the guideline.
…It is great to have diabetic guideline, but the lack 
of resources is a really challenging. How can doctors 
comply with the recommendation to do the HbA1c 
test three times yearly while the HbA1c kits are 
lacking or at least available with limited amounts… 
Alternatively, doctors use Fasting Blood Sugar which 
gives inaccurate findings in which many patients 
come to clinics with over-fasting state and this affects 
the results… So doctors are enforced to give inappro-
priate interventions. (Senior doctor, MoH)
A wide consistency across all the MoH participants in 
the suggestion of allocating a specific budget to secure 
the continuous availability of medicines and lab investi-
gations for all chronic diseases and the diabetic patients 
in particular. A common suggestion elicited by the MoH 
and UNRWA participants was recruiting more doctors or 
nurses, and to hire more specialists such as endocrinolo-
gists, diabetes nurses, psychologists and dieticians.
Time constraints
The time constraints was highlighted as a significant 
barrier against the guideline adherence among partic-
ipants in the UNRWA settings. Time factor was charac-
terised by the view that there was inadequate time for 
implementing the guideline recommendations in a proper 
way. The majority of the participants claimed that many 
of professionals were enforced to shorten the consulta-
tion time due to the large number of daily patients seen. 
Some participants claimed that the consultation time 
with the UNRWA clinics is around 2.5 min. They believed 
that such contact time is totally not enough, so they are 
in favour of increasing time to 4 min in average. Interest-
ingly, the MoH interviewees admitted that the workload 
within the UNRWA clinics is heavier than the MoH due to 
the large number of patients seen in the UNRWA clinics. 
The UNRWA nurse participants also perceived the lack of 
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time as a main challenge to be complied with the recom-
mendations. They acknowledged that nurses find difficul-
ties in properly assessing the patients, listening to their 
complaints or providing useful health education due to 
time constraint and increased workload.
…the doctors in the UNRWA see around 70–80 cases 
daily. It is not easy to provide a standardized care to 
all diabetic patients all the times. Sometimes we are 
enforced to give only 2–3 min for each patient, other-
wise, other patients waiting outside might not be able 
to wait more…so they try to show their annoyance by 
knocking the office door many times… (Senior doc-
tor, UNRWA)
…I think the full adherence to the diabetic guideline 
adds extra-burden on an already exhausted nurses…
the nurses are overwhelmed with their routine as-
signed tasks… (Senior nurse, UNRWA) 
A general suggestion was indicated by the UNRWA 
participants to scientifically analyse the workload across 
all the disciplines and accordingly reallocate the human 
resources. Another proposition was to make the current 
appointment system more restricted.
Lack of clinical audit and feedback
The lack of regular audit of performance was reported 
by the majority of the MoH interviewees to be a major 
barrier to guideline adherence. Some described the 
current monitoring as a non-systematically routine tasks 
done by an assigned supervisors. Others described it as 
an inspection mission enforced by the higher level in 
case of alarming errors. The participants admitted that 
even the feedback is limited to only providing some clin-
ical comments that are rarely effective in changing the 
professional behaviour. The respondents argued that the 
inability to institutionalise the diabetic guideline into 
clinical routines was due to the lack of effective and well-
planned A&F. Some of the participants suggested to use 
the most appropriate ways in using the feedback.
…Yes it can be said that we don’t properly follow up 
our performance…often we rely on the monthly re-
ports to monitor and measure the performance and 
achievement. (Senior doctor, MoH)
Some supervisors do their job in improper man-
ner…they just try to detect errors and blame others. 
(Senior nurse, MoH)
Contrary to the situation in the MoH, all the UNRWA 
key informants reported the clinical audit has been insti-
tutionalised in their system as a main function done by 
all the supervisory positions. They stated that they use 
various approaches for monitoring the guideline adher-
ence such as field visit, direct observation, files auditing 
and the e-health programme.
As a bureaucratic system like the UNRWA, monitor-
ing is one of the most prominent managerial function 
we do. We can say that we spend 15% of our time in 
monitoring. (Senior doctor, UNRWA)
Guideline-related barriers
Guideline trustworthiness
Discussion of credibility of the content of the diabetes 
guideline took an important part of the interviews, and 
revealed number of issues identified as important barriers to 
guideline adherence. Many doctors in both settings shared 
thoughts about the quality of evidence on which the guide-
line were based, which impacted the providers’ adherence 
to the diabetes guideline. They claimed that the research 
evidence rigour were frequently not mentioned within 
the guideline itself. Although some of the interviewees 
had a trust in the guideline developers, they were not sure 
which methodology was used in developing the guideline 
or at least how the recommendations were finalised. The 
participants in the UNRWA reported that the develop-
ment of their guidelines always performed externally with 
full reliance on the WHO guidelines. Many of the inter-
viewees were familiar that the guideline developers adapted 
it according to the local context. They had a concern on 
such adaptation, which might be negatively affected by the 
content of the final recommendations. Despite the fact that 
this guideline was adapted from international guidelines 
as credible sources, some of the respondents believed that 
such adaptation was most likely to be deviated from the 
original evidences.
…Now the healthcare professionals are more aware 
about the meaning and the value of research evi-
dence…during our meetings with them, they discuss 
the new evidences in diabetic care…they want to fol-
low the international guidelines because of their cred-
ibility and originality…  (Senior doctor, UNRWA)
Outdated guideline
One key subtheme barrier that was frequently raised by 
the majority of the interviewees in both settings was the 
outdated guideline. Some of them stated that more than 
eight years had passed since the last update of current 
diabetes guideline. Others claimed that some information 
or even recommendations were occasionally updated based 
on the needs and the availability of resources.
Some qualified doctors usually search in scientific 
websites and review the latest evidences in the treat-
ment of diabetes, for example ‘new antidiabetic 
medication’, but unfortunately, they can’t apply such 
evidence because it is not mentioned in the diabetic 
guideline. (Senior doctor, MoH)
…I do believe that the most factor hindering the 
UNRWA professionals from being adherent to guide-
line recommendations is the non-up-to-date guide-
line. (Senior doctor, UNRWA).
However, it has been repeatedly suggested by all the key 
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the guideline; for instance, each 5 years at maximum. 
They also suggested forming a committee with specific 
responsibilities of regularly reviewing the updated 
research evidences relevant to the diabetes diagnosis and 
management.
dIsCussIOn
summary of the results
We performed a qualitative study and explored the main 
barriers influencing the adherence to diabetes guideline 
using the framework by Cabana et al. Our analysis proved 
that using the framework by Cabana et al was effective in 
identifying factors that most likely hindered the guidelines 
adherence. The analysis revealed a considerable variations 
in perceiving and experiencing the barriers of guideline 
adherence in the PHC-MoH and the PHC-UNRWA. The 
environmental-related and guideline-related barriers 
were the most prominent factors influencing the guide-
line adherence. The outdated guideline and the lack of 
A&F were the two emerged subthemes.
Comparison with the existing literature
The main themes and subthemes that emerged from the 
analysed interviews with senior doctors and nurses are 
discussed below.
lack of reimbursement
The MoH participants in the interviews intensively 
discussed the low salaries and its effects on the perfor-
mance. They claimed that the lack of financial incen-
tive was the strongest barrier against the guideline 
adherence. Despite the fact that monetary rewards can 
improve employee motivation and performance,13 they 
do not always produce desirable outcomes. Such finding 
might support a recently published study showing that 
the guideline adherence among UNRWA employees was 
low14 even though their monthly salaries were one time 
and half more than their counterparts in the MoH. In the 
MoH, the average monthly salary of doctors and nurses 
was about US$1300 and US$800, respectively, while in 
UNRWA, it was about US$2000 and US$1200 for doctors 
and nurses, respectively. Such apparently inadequate 
salaries had not forced the governmental staff to engage 
in the private sector due to its limited scale in Gaza and 
lower wages as well. However, there are two possible expla-
nations for the poor desirable outcomes of the financial 
incentives. First, high amounts of monetary incentives 
may lead to poor performance levels as a result of exag-
gerated increased fear of failure.15 Second, employees 
can develop a sense of entitlement to certain amounts of 
payment,16 otherwise, they can feel dissatisfied and have 
negative reactions if they do not get amount less than 
their expectations.17 A prominent suggestion by the MoH 
interviewees was to link the financial incentives with guide-
line adherence. This suggestion seems to be incomplete 
if compared with a study that provided recommendations 
on how to effectively use monetary rewards.18 One of the 
main suggestions is strongly link the monetary rewards 
with performance as much as possible, and not to irrele-
vant factors such number of years of work or indisputably 
following supervisor’s instructions.19 Without a strong 
connection between pay and performance, employees 
are less likely to be motivated due to having doubt that 
increasing effort will result in additional pay.18 Another 
important suggestion is to use monetary and non-mon-
etary rewards. The reason is that non-monetary rewards 
can motivate employees in ways rather than the monetary 
rewards do.13 For example, valuable training and develop-
ment opportunities as rewards for good performance can 
motivate employees and increase their knowledge and 
skills.20 It appears that determination of the most influ-
encing motivators on guideline adherence needs to be 
further studied and rigorously analysed.
lack of resources
The MoH key informant interviewees cited lack of 
resources as a key barrier to the adherence of diabetes 
guideline. Shortages in staff and logistics such as medi-
cines and lab tests were the most frequently mentioned. 
Notably, in a context like the Palestinian one where dete-
riorating political and economic situation is predomi-
nant, ensuring a continuous supply of medications and 
medical and laboratory consumables is really challenging. 
Due to the obvious financial limitation, most of these 
supplies come as donations. This sort of donation is often 
linked with donors’ budget and priorities. In many low-in-
come and middle-income countries (LMICs), the medical 
resources are insufficient and the basic services are often 
unavailable.21 WHO estimates that the average availability 
of essential drugs in LMICs is 35% in public sector facil-
ities and 66% in the private sector.22 In the Palestinian 
healthcare system, it seems that tackling the issue of irra-
tional medicine use is considered to be quite essential to 
allow for optimal utilisation of scarce resources and to 
improve healthcare delivery. Reinforcing the rational use 
of medicines requires effective policies as well as adequate 
collaboration between healthcare professionals, patients 
and entire communities.23 Although the lack of resources 
is extremely challenging in the Palestinian context, the 
decision makers are strongly invited to judge the most 
efficient ways for rational use of the scarce resources.24
lack of clinical audit and feedback
A first key subtheme expressed by the MoH key infor-
mants was the lack of A&F in which many of them 
thought it was a barrier against the guideline adherence. 
This finding could be attributed to the view that the 
supervision concepts were generally lacking in the MoH 
health facilities and mostly focused on detecting errors 
and blaming employees rather than providing coaching, 
support and training.25 In guidelines implementation, 
A&F has been used to increase guideline adherence in 
many different settings and conditions.26–28 Several studies 
including a meta-analysis pointed out that the audited 
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compared with those services without auditing.29–31 In the 
same time, systematic reviews indicated that the effect of 
A&F is generally modest in improving performance.32 33 
However, it seems that the effectiveness of A&F depends 
on baseline performance and how the feedback is 
provided.33 Ivers et al in their systematic review concluded 
that the 'feedback may be more effective when baseline 
performance is low, it is provided more than once, it is 
delivered in both verbal and written formats, the source 
is a supervisor or colleague and when it includes both 
explicit targets and an action plan’.33 It appears sensible 
to suggest that the efforts to change the MoH provider 
practice should be targeted at behaviours for which there 
is evidence supporting the most appropriate practices of 
A&F in order to enhance the guideline adherence.
time constraints
Time constraints with a heavy workload were qualita-
tively perceived as a major barrier to guideline adher-
ence among UNRWA participants. They simply felt that 
there was not enough time to deliver the diabetic care 
according to the guideline recommendations. Similar 
result revealed the majority of the key informants 
reported that the main barriers that prevented them from 
adhering to guideline recommendations of diabetes and 
hypertension were the time constraints and increased 
workload.34 Higher provider workloads have potentially 
negative impact on patients’ quality of care,35 patient satis-
faction36 and job satisfaction.37 Time constraints largely 
increase with higher workloads. An experimental study 
pointed out that time pressure enforced the general prac-
titioners to partially follow the guideline (eg, conducting 
limited clinical examination, asking significantly less clin-
ical questions and providing less advice on lifestyle).38 
The UNRWA participants claimed that many profes-
sionals were enforced to shorten the consultation time to 
around 2.5 min due to the large numbers of daily patients 
seen. A recently systematic review found that average 
consultation length differed across the world, ranging 
from 1.7 min in Pakistan, 7.1 min in Egypt, 6.9 min in 
Iran, 8.2 min in Turkey, 21 min in the USA to 22.5 min 
in Sweden.39 The review concluded that short consulta-
tion length is likely to adversely affect patient healthcare 
and physician workload and stress,39 as well reduce the 
range of services provided in primary care.40 41 Therefore, 
it could be highly suggested that the issuing of guide-
lines should be preceded by workload analysis studies so 
that barriers to the implementation are minimised. In 
this regard, extra efforts might be done to implement 
more structured procedures such as recruiting adequate 
numbers of professionals and giving of specific appoint-
ment times to individual patients.
lack of guideline trustworthiness
In both settings (PHC-MoH and PHC-UNRWA), most of 
the interviewees expressed clear concern on the credi-
bility and quality of the evidences on which the guidelines 
were based. This finding was supported by a recent study 
that assessed the methodological quality of the current 
diabetic guideline using the Appraisal of Guidelines, 
Research and Evaluation (AGREE) II instrument and 
revealed that its rigour of evidences was low.42 Previous 
studies showed that adherence to recommendations 
based on scientific evidence is higher than the recom-
mendations that are not supported with evidence.43 44 
Guideline recommendations should always be accompa-
nied by a systematically derived summary of best available 
evidence that rates evidence quality and links it with the 
strength of recommendations, ideally using the Grading 
of Recommendations Assessment, Development and 
Evaluation (GRADE) system.45 The GRADE approach 
provides ‘a comprehensive, explicit and transparent 
methodology for grading the quality of evidence and 
strength of recommendations about the management 
of patients’.46 Surprisingly, even the WHO recommenda-
tions are often inconsistent with GRADE guidance, partly 
due to shortcomings in their understanding of GRADE.47 
Ensuring optimal application of GRADE at WHO and 
elsewhere likely requires further training in GRADE 
methods for guideline development of group members.
Another striking point raised by many of the key infor-
mants was on their concerns that the guideline adaptation 
and forming the final recommendations were most likely 
to be deviated from the original evidences. Similarly, a 
recent study pointed out that the Indonesian diabetes 
guideline which was adapted from international guide-
lines lacks the transparency in adaptation.48 However, 
most of the guidelines in LMICs are adapted from pre-ex-
isting international guidelines. A recent systematic review 
on diabetes guidelines in non‐Western countries found 
that 79% of the guidelines were based on recommenda-
tions from other national or international guidelines.49 
Several studies revealed that there are considerable varia-
tions and even conflicting recommendations concerning 
type 2 DM management from different guidelines.50 51 
Implementation of evidence‐based practice criteria such 
as those proposed by ADAPTE collaboration should be 
followed when guideline is derived from other guidelines 
to be used in different context.48 Instead of developing 
new guidelines, the ADAPTE collaboration was estab-
lished to develop a stepwise and systematic approach to 
improve efficiency of guideline development, reduce 
duplication of efforts and produce valid and high-quality 
guidelines that are relevant for use in a local context.52 53
Outdated guideline
A second key subtheme elicited from the analysed 
interviews in both settings (MoH and UNRWA) was the 
outdated guideline. It appears that neither the guideline 
expiration date nor the systematic updating process was 
considered. Most organisations do not have formal proce-
dures for updating their guidelines.54 An international 
survey found that half of the organisations do not have a 
formal process to determine when a guideline becomes 
invalid.55 A systematic review of 35 methodological hand-
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that generally the updating process is poorly prescribed.56 
Shekelle et al analysed the validity of a cohort of guide-
lines and indicated that 90% of guidelines were still 
valid in 3.6 years, but 50% were outdated in 5.8 years.57 
However, there is no fixed lifespan for a guideline, an 
update every 3–5 years is generally recommended.55 57–59 
Various studies have consistently identified common diffi-
culties in updating guidelines; lack of standardised time 
for guideline updating, lack of standardised and rigorous 
process for updating, lack of efficient review system to 
identify recent and relevant evidence; decisions on partial 
or full updating and the cost-effectiveness of updating a 
guideline.55 59 60 It can be suggested that the guideline 
developers should determine a time period for updating, 
and provide more explicit formal procedures of updating 
the diabetes guideline in order to assure guideline validity.
strengths and limitations
The strength of this study lies in the fact that it is the first 
qualitative study recruiting the framework by Cabana 
et al that has provided in-depth understanding of the 
factors hindering the adherence to the Palestinian 
diabetes guideline. Interviews explored determinants 
of adherence to diabetes guideline from different work 
settings and positions through a careful selection of the 
study sample in order to help in transferability of find-
ings. Maximum variation is a sampling method which 
is likely to allow for the application of the study to a 
wider audience.10 Participants were contacted (member 
checks) to confirm the researchers’ guesses or feelings 
related to the transcripts. The researcher’s experience 
and background in quality improvement and practice 
guidelines enabled him to understand the meaning of 
some interview responses that might have been difficult 
to understand otherwise. Each transcript was checked 
several times against the digital recording from which it 
had been made. In the data analysis stage, the researcher 
analysed the data in each transcript independently with 
a PhD researcher of health policy and in case of any 
discrepancies, a consensual conclusion about the codes 
and themes was arrived at after consulting a third expert 
and the local academic advisor. A limitation of this study 
was that only the perspectives of senior doctors and 
nurses were included in this study. The views and percep-
tions of frontline professionals should be addressed in 
future studies. The other limitation is that we focused on 
barriers of adherence to the diabetes guideline as a whole 
rather than on its key recommendations.
Implications for policy and practice
The following points are suggested recommendations 
and policy implications:
 ► Multifaceted implementation strategies targeting the 
main barriers elicited from this study are extremely 
required for addressing the knowledge, incentives, 
organisational resources, the rigour of guideline 
development and time constraints. Recent evidence 
concluded that a tailored implementation strategy 
targeting perceived barriers is useful for improving 
the guideline adherence.61
 ► To improve the quality of our current and future 
guidelines, a systematic and rigorous approach in 
synthesis of guideline recommendations is extremely 
advised. The AGREE II instrument should be incor-
porated as a gold standard for developing, evaluating 
or updating the Palestinian CPGs. Instruments like 
AGREE II, GRADE and Preferred Reporting Items for 
Systematic Reviews and Meta-Analyses could be quite 
useful tools and contribute positively in the improve-
ment of guidelines quality and transparency.
 ► It seems sensible to deeply analyse what could moti-
vate the Palestinian healthcare professionals prior 
to any guideline implementation. Hence, the Pales-
tinian national payment method and the incentive 
scheme should be carefully reviewed and redesigned 
taking into account the monetary and non-monetary 
incentives.
 ► Although insufficient resources is extremely chal-
lenging in the Palestinian context, the decision 
makers are strongly invited to judge the most efficient 
ways for rational use of the scarce resources.
 ► Workload analysis studies are highly demanded prior 
to any potential development of clinical guidelines.
 ► For future research, the framework 
by Caban et al should be tested alongside randomised 
trials to test the causal factors of guideline adherence/
non-adherence.
COnClusIOn
To the best of our knowledge, this is the first study 
using the framework by Cabana et al to investigate the 
main barriers influencing the adherence to diabetes 
guideline. Our analysis proved that using the frame-
work by Cabana et al was effective in identifying factors 
that most likely impeded the guidelines adherence. The 
analysis identified a wide range of barriers against the 
adherence to guideline for DM within the PHC-MoH and 
PHC-UNRWA. The environmental-related and guide-
line-related barriers were the most prominent factors 
influencing the guideline adherence. In the PHC-MoH, 
the most perceived barriers to guideline adherence were 
lack of reimbursement, lack of resources and lack of the 
guideline trustworthiness, whereas the time constraints 
and the lack of the guideline trustworthiness were the 
most prominent barriers in the PHC-UNRWA. The two 
key subthemes elicited from the qualitative analysis were 
the outdated guideline and the lack of A&F. The results of 
this study can help in explaining why doctors and nurses 
in both settings do not adhere to diabetes guideline. Our 
study can inform the policy makers and senior managers 
to develop a tailored intervention that can target the 
elicited barriers through a multifaceted implementation 
strategy.
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